Editas Medicine, Inc.
EDIT
$2.37
$0.2612.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -199.84M | -236.86M | -251.23M | -237.09M | -210.57M |
| Total Depreciation and Amortization | 5.85M | 4.94M | 4.53M | 4.02M | 4.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.48M | 25.32M | 22.23M | 19.34M | 17.24M |
| Change in Net Operating Assets | -10.12M | 5.24M | 16.27M | 3.45M | 7.46M |
| Cash from Operations | -179.62M | -201.36M | -208.21M | -210.28M | -181.76M |
| Capital Expenditure | -1.09M | -3.58M | -7.07M | -8.83M | -9.59M |
| Sale of Property, Plant, and Equipment | 151.00K | 151.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.50M | 217.40M | 230.35M | 170.97M | 203.62M |
| Cash from Investing | 169.57M | 213.97M | 223.28M | 162.15M | 194.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.29M | 9.12M | 2.03M | 783.00K | 1.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 52.37M | 52.37M | 52.37M | 55.24M | -- |
| Cash from Financing | 78.66M | 61.49M | 54.40M | 56.03M | 1.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.61M | 74.10M | 69.47M | 7.89M | 13.29M |